Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROOLIFE GROUP LTD Capital/Financing Update 2020

Aug 25, 2020

65712_rns_2020-08-25_ab7a9380-27d2-41ba-9d2a-694769c4c008.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [167 x 73] intentionally omitted <==

26 August 2020

RooLife Rights Issue Timetable Clarification

e-Commerce and digital marketing company RooLife Group Ltd ( ASX: RLG ) (“ RooLife Group ” or the “ Company ”) advises that the timetable in the covering release to the Prospectus for its pro-rata nonrenounceable rights issue released on 25 August 2020 disclosed an Ex-Date of 8 August 2020. As disclosed in the Company’s announcements of 21 August 2020 and in the Prospectus lodged on 25 August 2020, the Ex-Date is 8 September 2020.

The following is the timetable as disclosed in the Prospectus.

Indicative Timetable

Indicative Timetable
Event Date
Announce Rights Issue and lodgement of Appendix 3B withASX Friday 21 August 2020
Lodgement of the Prospectus with ASIC and ASX Tuesday25 August 2020
Ex-Date for Rights Issue(5.00pm WST) Tuesday8 September 2020
Record Date(5.00pm WST) Wednesday9 September 2020
Prospectus despatched to Shareholders Monday14 September 2020
Last date to extend the ClosingDate Monday21 September 2020
ClosingDate(5.00pm WST) Thursday24 September 2020
Deferred settlement tradingoccurs(if agreed byASX) Friday25 September 2020
Announce results of issue and residual securities Tuesday29 September 2020
Issue Date – deferred settlement tradingends Thursday1 October 2020
Commencement of tradingof new Shares and new Options Friday2 October 2020

ENDS

Issued by : RooLife Group Ltd

Authorised by: The Managing Director / CEO of the Company

For further information, please visit the RooLife website at www.roolifegroup.com.au or contact:

Bryan CarrManaging DirectorPh: +61 8 6444 1702Email: [email protected] Peter NesvedaCorporate Affairs & International Investor RelationsPh: +61 412 357 375[email protected]